Late-StageResearch compoundATC · N06AX12Rx · Prescription only (Rx), prescribed for MDD and smoking cessation

Bupropion

Norepinephrine-dopamine reuptake inhibitor (NDRI) atypical antidepressant. Indications: MDD, seasonal affective disorder, smoking cessation (Zyban). No sexual dysfunction, minimally sedating.

Available at

The links above are labelled third-party affiliate links. MolekulaX does not sell and does not verify product quality.

Bupropion vial

WHAT IS BUPROPION?

Detailed overview

Bupropion is an atypical antidepressant developed by GlaxoSmithKline (Wellbutrin, FDA 1989). Its NDRI (norepinephrine-dopamine reuptake inhibitor) and nicotinic receptor antagonist mechanism distinguishes from SSRI/SNRI: no sexual dysfunction or weight gain, not sedating, supports smoking cessation (Zyban brand FDA 1997). FDA-approved indications: MDD, seasonal affective disorder (SAD), smoking cessation. Jorenby 1999 (NEJM PMID 10080847) trial showed 1-year abstinence 30.3% on bupropion+nicotine patch, vs 16.4% placebo. Hewett 2010 meta-analysis of 6 MDD trials demonstrated SSRI-comparable efficacy with better tolerability.

ATC code

N06AX12

Prescription

Prescription only (Rx)

Mechanism

NDRI + nicotinic receptor antagonist

Half-life

~21 h (hydroxybupropion metabolite 20-37 h)

Onset

1-2 weeks (motivation, focus), 4-6 weeks (full AD effect)

Data console

Lab data

/lab/molecular-data.jsonLIVE
> ATC codeN06AX12
> PrescriptionPrescription only (Rx), prescribed for MDD and smoking cessation
> MechanismModerate norepinephrine and dopamine reuptake inhibition (N…
> Half-life~21 h (parent); hydroxybupropion metabolite 20-37 h, similar activity
> Onset1-2 weeks (motivation, focus, energy), 4-6 weeks (full antidepressant response)
> BioavailabilityNot characterized as absolute (no IV formulation exists); rapid oral absorption, Tmax ~3 h – FDA Wellbutrin label

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • BOXED WARNING: increased risk of suicidal thoughts and behavior in children, adolescents and young adults (<25 yrs) at treatment start or dose change; close monitoring required.
  • Dose-dependent seizures: ~0.1% at standard dose (≤300 mg/day), ~0.4% at 450 mg/day, exponential above; the hallmark serious risk. Respect max dose (SR 400, XL 450 mg/day); do not crush tablets.
  • Insomnia (15-20%), dry mouth (10-15%) and headache (~10%); to limit insomnia, take the last dose by early afternoon (around 5 pm).
  • Agitation, anxiety, restlessness and tremor, especially in the first weeks; an activating, non-sedating profile with a narrow therapeutic window.
  • Blood pressure elevation (dose-dependent NDRI effect); monitor BP at initiation, especially when combined with nicotine replacement or other sympathomimetics.
  • Weight loss / reduced appetite (5-8%); weight-neutral or weight-reducing unlike SSRIs (often a benefit, but a concern in eating disorders).
  • Neuropsychiatric events: may trigger mania/hypomania in bipolar patients (NDRI activation); rarely psychotic symptoms, hallucinations or paranoia, mainly at high doses.
  • Hypersensitivity reactions: rash, urticaria, pruritus; rarely serum-sickness-like reaction or Stevens-Johnson syndrome; discontinue if rash persists or worsens.

Contraindications · 4

  • Seizure disorder (epilepsy) history or known predisposition
  • Eating disorders (bulimia, anorexia nervosa) – elevated seizure risk
  • Acute alcohol or benzodiazepine withdrawal (seizure risk)
  • Concurrent or within-14-days MAOi use (hypertensive crisis)

Related Pharmaceuticals

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Bupropion?

Educational drug info from official sources (PubMed, FDA, EMA). Does NOT replace medical consultation or the SmPC. Talk to your doctor!

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: June 19, 2026

The information here is for educational and scientific purposes only. Medication use requires medical consultation and a prescription. The indications, dose ranges, and side effects listed here do NOT replace the official Summary of Product Characteristics (SmPC) or consultation with a physician. Do not start or stop any medication on your own. In an emergency, call your local emergency number.